Millions of people rely on medications to manage heartburn, acid reflux, and other digestive problems.

Among the most widely used are proton pump inhibitors, commonly known as PPIs. This group includes familiar medications such as omeprazole, lansoprazole, and pantoprazole.

PPIs can be highly effective at reducing stomach acid and are commonly used to treat conditions such as gastroesophageal reflux disease, stomach ulcers, and other acid-related problems.

But questions about their long-term use have continued to attract scientific attention.

One area that has generated particular interest is whether prolonged PPI use could be associated with a higher risk of dementia.

A 2023 study reported an association between extended PPI use and dementia among middle-aged adults. However, the finding does not establish that omeprazole or other PPIs cause dementia.

That distinction is important.

Here is what researchers have found, what scientists think might explain the association, and what people taking these medications should know.

What Are Proton Pump Inhibitors?

Proton pump inhibitors are medications that reduce the amount of acid produced by the stomach.

They work by blocking a system in stomach cells known as the proton pump, which plays a major role in acid production.

Common PPIs include:

• Omeprazole

• Lansoprazole

• Pantoprazole

• Esomeprazole

• Rabeprazole

Doctors may recommend these medications for a variety of conditions, including frequent acid reflux, gastroesophageal reflux disease, peptic ulcers, and certain situations involving medications that can irritate the stomach.

For many patients, PPIs are taken for a limited period.

However, some people remain on them for much longer because their symptoms or underlying medical condition require continued treatment.

That is where researchers have become interested in the potential effects of long-term exposure.

What Did the Dementia Study Find?

The research that attracted attention analyzed health data from thousands of adults who did not have dementia when they entered the study.

The participants were between 45 and 64 years old, and researchers followed them over time while examining medication use and subsequent health outcomes.

Of the 5,712 participants included in the analysis, nearly 1,500 were taking PPIs.

Researchers adjusted their analysis for several factors that could influence dementia risk, including demographic characteristics and existing health conditions.

They reported that people who had used PPIs for an extended period had a higher observed risk of developing dementia than those who had not used the medications for long periods.

According to the study, long-term users had approximately a 33% higher relative risk of developing dementia.

However, that number needs to be interpreted carefully.

A 33% higher relative risk does not mean that one-third of people taking omeprazole will develop dementia.

It also does not mean that taking a PPI directly causes dementia.

The study found an association, which is different from proving cause and effect.

Why the Difference Between Association and Cause Matters

Imagine researchers discover that people who regularly take a particular medication are more likely to develop dementia.

There are several possible explanations.

The medication itself could potentially contribute to the outcome.

But another possibility is that people taking the medication have underlying health conditions that independently affect their risk.

This is known as confounding.

For example, people who regularly experience significant gastrointestinal problems may differ from people who do not take PPIs in other ways that researchers cannot completely measure.

Lifestyle, diet, other medications, cardiovascular health, metabolic conditions, and many other factors can potentially influence dementia risk.

Even when researchers statistically adjust for known differences, observational studies cannot eliminate every possible source of confounding.

That is why scientists generally do not interpret an observational association as proof that a medication causes a disease.

Does Omeprazole Cause Dementia?

Based on the available evidence described in the study, it would be inaccurate to say that omeprazole has been proven to cause dementia.

The research identified a possible relationship between long-term PPI use and dementia risk.

It did not establish that the medication was responsible for the condition.

The researchers themselves emphasized that additional studies are needed to determine whether the association can be reproduced in other populations and, importantly, to understand why it might exist.

This distinction is especially important for people who have been prescribed PPIs for a legitimate medical reason.

Stopping an effective medication simply because of a headline about dementia may create other health problems.

How Long-Term Use May Be Different

The study did not suggest that every person taking a PPI has the same level of risk.

Researchers were particularly interested in longer-term exposure.

In the analysis, participants who had taken PPIs for several years were the group in which the association became apparent.

Shorter-term use did not show the same relationship in the study.

That does not mean short-term use is guaranteed to have no effect, nor does it prove that long-term use causes dementia.

It simply means that the researchers observed a difference associated with longer exposure.

The length of treatment is therefore something patients and doctors should periodically review.

Could Vitamin B12 Be Involved?

Scientists have proposed several possible explanations for the observed association.

One possibility involves vitamin B12.

Stomach acid helps the body process and absorb nutrients from food. Long-term suppression of stomach acid may influence the absorption of certain nutrients in some people.

Vitamin B12 is particularly interesting because inadequate levels can be associated with neurological symptoms, including problems with thinking, memory, balance, and nerve function.

Researchers have therefore wondered whether changes in B12 levels could potentially help explain an association between long-term acid-suppressing medication and cognitive problems.

However, this remains a hypothesis.

In the study discussed here, researchers did not have B12 measurements for the participants, meaning they could not determine whether differences in B12 status explained the results.

That is an important limitation.

What About Amyloid in the Brain?

Another proposed explanation involves amyloid.

Amyloid proteins are closely associated with Alzheimer’s disease, the most common cause of dementia.

Some laboratory and biological research has explored whether medications that alter certain cellular processes could potentially influence pathways involved in amyloid metabolism.

Neurologists have suggested that it is biologically plausible that PPIs could influence enzymes or other processes related to amyloid.

But a biological hypothesis is not the same thing as evidence that the medication causes Alzheimer’s disease in humans.

More research is necessary before scientists can determine whether this proposed mechanism has any meaningful effect on dementia risk in people taking PPIs.

Dementia Has Many Risk Factors

It is also important to remember that dementia is not caused by one single factor.

Age is one of the strongest known risk factors.

Other factors can include genetics, cardiovascular health, diabetes, high blood pressure, smoking, physical inactivity, and other aspects of overall health.

Some causes of cognitive impairment may also be treatable or reversible.

This complicated picture makes it difficult to determine whether one medication contributes independently to dementia risk.

A person’s entire medical history matters.

Why You Shouldn’t Stop Omeprazole Suddenly

A concerning headline can understandably make someone want to stop taking their medication immediately.

However, that is not generally a good idea without speaking with a healthcare professional.

PPIs are prescribed because they can provide important benefits.

They may help control significant reflux symptoms, promote healing of damaged tissue, and protect against complications in certain patients.

Stopping treatment suddenly can cause acid-related symptoms to return.

Some people may also experience a temporary increase in acid production after stopping long-term PPI therapy, a phenomenon often described as rebound acid hypersecretion.

The safest approach is to discuss the medication with your doctor before making major changes.

Should Everyone Taking a PPI Be Concerned?

No.

The study does not mean that everyone taking omeprazole, pantoprazole, or another PPI will develop dementia.

It also does not mean that patients should avoid these medications when they have a clear medical reason to use them.

Instead, the findings highlight the importance of reviewing long-term medication use.

If someone has been taking a PPI for years, it may be reasonable to ask their healthcare provider whether continued treatment is still necessary, whether the current dose is appropriate, and whether another approach could be suitable.

The answer will depend on the individual’s medical history.

Lifestyle Changes May Help Manage Acid Reflux

Medication is not the only tool available for managing acid reflux.

For some people, lifestyle changes can reduce symptoms.

Potential strategies may include maintaining a healthy weight when appropriate, avoiding meals close to bedtime, identifying foods that consistently trigger symptoms, and elevating the upper body during sleep when recommended.

Common triggers can vary significantly from one person to another.

Some people notice problems after consuming large meals, fatty foods, alcohol, coffee, chocolate, or spicy foods, while others may not.

Rather than eliminating large numbers of foods unnecessarily, it can be useful to identify personal triggers.

However, lifestyle changes should not replace prescribed treatment without discussing the change with a healthcare professional.

When Should You Talk to Your Doctor?

If you have been taking a PPI for a long time, consider discussing it during your next medical appointment.

Questions you might ask include:

• Do I still need this medication?

• Is my current dose appropriate?

• How long should I continue taking it?

• Could I safely reduce the dose?

• Are there alternative treatments for my condition?

• Do I need monitoring for nutrient deficiencies or other side effects?

A doctor can evaluate the benefits and potential risks in the context of your individual health.

This is much more useful than making a decision based solely on a single study or social media headline.

The Bigger Picture

Research into the possible relationship between proton pump inhibitors and dementia is important, but it is still evolving.

The reported association between long-term PPI use and dementia deserves further investigation.

At the same time, the evidence does not justify telling people that omeprazole or other PPIs have been proven to cause dementia.

Scientists still need to determine whether the observed relationship is causal, whether other factors explain part of the association, and whether particular groups of patients face different levels of risk.

For now, people taking PPIs should not panic.

They should also not stop prescribed medication without medical advice.

Instead, the sensible approach is to review long-term medication use with a healthcare professional and make decisions based on the individual’s medical needs.

What Patients Should Remember

Omeprazole and other proton pump inhibitors are widely used and can provide important benefits for people with acid-related conditions.

Research has raised questions about a possible association between long-term PPI use and dementia, but an association is not proof of causation.

Potential explanations involving vitamin B12 and brain chemistry are still being investigated, and more research is needed.

The most important takeaway is simple: don’t let a frightening headline make the decision for you.

If you take omeprazole or another PPI regularly, talk with your doctor about whether you still need it, how long you should take it, and whether your treatment plan should be adjusted.

Medication decisions are personal, and the potential benefits of treatment must always be weighed against potential risks.

For now, the research provides a reason for continued scientific investigation—not a reason for patients to suddenly abandon a medication that may be helping them.